低脂、地中海或低碳水减重饮食对血清尿酸及心血管代谢危险因素的影响:DIRECT试验二次分析
该研究为DIRECT随机对照试验的二次分析,纳入235例中度肥胖参与者,随机接受低脂限热量、地中海限热量或低碳水不限热量饮食。三种饮食在6个月和24个月均降低血清尿酸且组间无差异,高尿酸血症者降幅更大,同时体重、HDL-C、甘油三酯和胰岛素等心血管代谢指标改善。
要点
- 三种减重饮食均降低血清尿酸,6个月平均降48 μmol/L,24个月降18 μmol/L,组间无差异。
- 高尿酸血症者尿酸降幅更大,6个月降113–143 μmol/L,24个月降65–83 μmol/L。
- 体重和空腹胰岛素变化与尿酸变化独立相关,提示减重和改善胰岛素抵抗介导获益。
核心结论
- 非嘌呤聚焦的减重饮食可同时改善血清尿酸和心血管危险因素,可能通过减少肥胖和胰岛素抵抗介导。
- 不同减重饮食对尿酸的影响无显著差异,可根据患者合并症和偏好个体化选择。
研究设计与样本
- DIRECT试验的二次分析,使用235例中度肥胖参与者的储存样本。
- 随机分为低脂限热量(n=85)、地中海限热量(n=76)或低碳水不限热量(n=74)饮食。
- 在6个月和24个月评估血清尿酸变化,并分析高尿酸血症(SU≥416 μmol/L)亚组。
主要发现
- 全体参与者平均SU下降:6个月48 μmol/L,24个月18 μmol/L,饮食组间无差异(P>0.05)。
- 三种饮食组体重、HDL-C、总胆固醇:HDL-C比值、甘油三酯和胰岛素浓度在6个月均改善(P<0.05)。
- 校正协变量后,体重和空腹胰岛素浓度变化仍与SU变化相关(P<0.05)。
- 高尿酸血症亚组SU下降:6个月低脂113、地中海119、低碳水143 μmol/L(组内P<0.001;组间P>0.05)。
- 高尿酸血症亚组24个月SU下降:低脂65、地中海77、低碳水83 μmol/L(组内P<0.01;组间P>0.05)。
关键数值与推荐
- 高尿酸血症定义为SU≥416 μmol/L。
- SU平均下降幅度:6个月48 μmol/L,24个月18 μmol/L。
- 高尿酸血症者6个月SU降幅113–143 μmol/L,24个月降幅65–83 μmol/L。
临床怎么用
- 对于肥胖伴高尿酸血症患者,可推荐低脂、地中海或低碳水减重饮食,均可能降低尿酸并改善心血管代谢指标。
- 饮食选择可基于患者合并症和偏好个体化,以促进长期依从性。
局限性
- 为二次分析,结果需在更广泛人群中验证。
- 样本量235例,高尿酸血症亚组人数较少。
- 未报告尿酸降低与痛风发作等临床结局的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Weight loss diets may reduce serum urate (SU) by lowering insulin resistance while providing cardiometabolic benefits, something urate-lowering drugs have not shown in trials. We aimed to examine the effects of weight loss diets on SU and cardiometabolic risk factors. RESEARCH DESIGN AND METHODS: This secondary study of the Dietary Intervention Randomized Controlled Trial (DIRECT) used stored samples from 235 participants with moderate obesity randomly assigned to low-fat, restricted-calorie (n = 85); Mediterranean, restricted-calorie (n = 76); or low-carbohydrate, non-restricted-calorie (n = 74) diets. We examined SU changes at 6 and 24 months overall and among those with hyperuricemia (SU ≥416 μmol/L), a relevant subgroup at risk for gout. RESULTS: Among all participants, average SU decreases were 48 μmol/L at 6 months and 18 μmol/L at 24 months, with no differences between diets (P > 0.05). Body weight, HDL cholesterol (HDL-C), total cholesterol:HDL-C ratio, triglycerides, and insulin concentrations also improved in all three groups (P < 0.05 at 6 months). Adjusting for covariates, changes in weight and fasting plasma insulin concentrations remained associated with SU changes (P < 0.05). SU reductions among those with hyperuricemia were 113, 119, and 143 μmol/L at 6 months for low-fat, Mediterranean, and low-carbohydrate diets (all P for within-group comparison < 0.001; P > 0.05 for between-group comparisons) and 65, 77, and 83 μmol/L, respectively, at 24 months (all P for within-group comparison < 0.01; P > 0.05 for between-group comparisons). CONCLUSIONS: Nonpurine-focused weight loss diets may simultaneously improve SU and cardiovascular risk factors likely mediated by reducing adiposity and insulin resistance. These dietary options could provide personalized pathways to suit patient comorbidity and preferences for adherence.
引用
- Yokose C, McCormick N, Rai SK, et al. Effects of Low-Fat, Mediterranean, or Low-Carbohydrate Weight Loss Diets on Serum Urate and Cardiometabolic Risk Factors: A Secondary Analysis of the Dietary Intervention Randomized Controlled Trial (DIRECT). Diabetes Care. 2020. PMID: 33082244. doi:10.2337/dc20-1002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。